NO993876L - 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater - Google Patents

3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater

Info

Publication number
NO993876L
NO993876L NO993876A NO993876A NO993876L NO 993876 L NO993876 L NO 993876L NO 993876 A NO993876 A NO 993876A NO 993876 A NO993876 A NO 993876A NO 993876 L NO993876 L NO 993876L
Authority
NO
Norway
Prior art keywords
oxide
derivatives
dimethylamine
oxime
oxime erythromycin
Prior art date
Application number
NO993876A
Other languages
English (en)
Norwegian (no)
Other versions
NO993876D0 (no
Inventor
Yi-Yin Ku
David A Riley
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO993876D0 publication Critical patent/NO993876D0/no
Publication of NO993876L publication Critical patent/NO993876L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO993876A 1997-02-13 1999-08-11 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater NO993876L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/800,009 US5864023A (en) 1997-02-13 1997-02-13 3'-N'oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives
PCT/US1998/001929 WO1998035976A1 (en) 1997-02-13 1998-02-03 3'-n-oxide, 3'-n-dimethylamine, 9-oxime erythromycin a derivatives

Publications (2)

Publication Number Publication Date
NO993876D0 NO993876D0 (no) 1999-08-11
NO993876L true NO993876L (no) 1999-08-11

Family

ID=25177295

Family Applications (1)

Application Number Title Priority Date Filing Date
NO993876A NO993876L (no) 1997-02-13 1999-08-11 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater

Country Status (25)

Country Link
US (1) US5864023A (cs)
EP (1) EP0966477B1 (cs)
JP (1) JP2001512456A (cs)
KR (1) KR100561326B1 (cs)
CN (1) CN1326865C (cs)
AR (1) AR012032A1 (cs)
AT (1) ATE252108T1 (cs)
AU (1) AU725274B2 (cs)
BG (1) BG64099B1 (cs)
BR (1) BR9807349A (cs)
CA (1) CA2279932C (cs)
CZ (1) CZ294481B6 (cs)
DE (1) DE69818977T2 (cs)
DK (1) DK0966477T3 (cs)
ES (1) ES2212266T3 (cs)
HU (1) HUP0001330A3 (cs)
IL (1) IL130697A0 (cs)
NO (1) NO993876L (cs)
NZ (1) NZ336482A (cs)
PL (1) PL187357B1 (cs)
PT (1) PT966477E (cs)
SK (1) SK284157B6 (cs)
TR (1) TR199901874T2 (cs)
WO (1) WO1998035976A1 (cs)
ZA (1) ZA98986B (cs)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100317907B1 (ko) * 1998-11-24 2001-12-24 김 완 주 신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
US6437106B1 (en) 1999-06-24 2002-08-20 Abbott Laboratories Process for preparing 6-o-substituted erythromycin derivatives
KR20010008496A (ko) * 1999-07-01 2001-02-05 유충식 6-오-메틸 에리트로마이신의 제조방법
KR100336447B1 (ko) * 1999-11-24 2002-05-15 민경윤 클라리스로마이신의 개선된 제조방법
KR20020070991A (ko) 1999-12-16 2002-09-11 테바 파마슈티컬 인더스트리즈 리미티드 클라리트로마이신 다형체 및 신규의 다형체 ⅳ의 제조 방법
BR0016992A (pt) * 2000-01-11 2002-12-31 Teva Pharma Processos para o preparo de polimorfos de claritromicina
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
EP1313486A1 (en) * 2000-02-29 2003-05-28 Teva Pharmaceutical Industries Ltd. Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same
CN1193036C (zh) * 2000-03-15 2005-03-16 韩美药品工业株式会社 制备甲红霉素-克拉霉素ⅱ型晶体的方法
KR20000037126A (ko) * 2000-04-08 2000-07-05 김용규 6-메틸 에리스로마이신 a의 제조방법
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) * 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
WO2005009368A2 (en) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004258944B2 (en) * 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
CA2533178C (en) * 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
AU2004264939A1 (en) * 2003-08-11 2005-02-24 Middlebrook Pharmaceuticals, Inc. Robust pellet
EP1653924A4 (en) 2003-08-12 2009-09-09 Middlebrook Pharmaceuticals In ANTIBIOTICS, USE AND FORMULATION ASSOCIATED
US8246996B2 (en) * 2003-08-29 2012-08-21 Shionogi Inc. Antibiotic product, use and formulation thereof
WO2005027877A1 (en) * 2003-09-15 2005-03-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2550983C (en) * 2003-12-24 2013-09-17 Advancis Pharmaceutical Corporation Enhanced absorption of modified release dosage forms
JP2008505124A (ja) * 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
US7694523B2 (en) * 2004-07-19 2010-04-13 Earthrenew, Inc. Control system for gas turbine in material treatment unit
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US20090054634A1 (en) * 2007-08-09 2009-02-26 Vinod Kumar Kansal Process for the preparation of clarithromycin

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331803A (en) * 1980-06-04 1982-05-25 Taisho Pharmaceutical Co., Ltd. Novel erythromycin compounds
JPS60214796A (ja) * 1984-04-06 1985-10-28 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシン類の製法
JPS61103890A (ja) * 1984-10-26 1986-05-22 Taisho Pharmaceut Co Ltd 6−0−メチルエリスロマイシンa誘導体
US4670549A (en) * 1985-03-18 1987-06-02 Taisho Pharmaceutical Co., Ltd. Method for selective methylation of erythromycin a derivatives
JPS61229895A (ja) * 1985-04-03 1986-10-14 Nippon Zeon Co Ltd 保護化デス−n−メチルエリスロマイシン誘導体
EP0254534A3 (en) * 1986-07-24 1991-04-17 William S. Robinson Erythromycin derivatives and compositions and use for inhibiting virus replication and disease
DE3782994T2 (de) * 1986-09-18 1993-04-08 Taisho Pharma Co Ltd Erythromycin-a-derivate und verfahren zu ihrer herstellung.
KR960000434B1 (ko) * 1986-12-17 1996-01-06 다이쇼 세이야꾸 가부시끼가이샤 에리스로마이신 a유도체 및 그의 제조 방법
JP2751385B2 (ja) * 1988-05-19 1998-05-18 大正製薬株式会社 エリスロマイシンaオキシム及びその塩の製造方法

Also Published As

Publication number Publication date
KR20000070985A (ko) 2000-11-25
DK0966477T3 (da) 2004-02-23
TR199901874T2 (xx) 2000-04-21
DE69818977D1 (en) 2003-11-20
SK97499A3 (en) 2000-01-18
EP0966477A1 (en) 1999-12-29
PL335301A1 (en) 2000-04-10
ATE252108T1 (de) 2003-11-15
ES2212266T3 (es) 2004-07-16
US5864023A (en) 1999-01-26
JP2001512456A (ja) 2001-08-21
SK284157B6 (sk) 2004-10-05
IL130697A0 (en) 2000-06-01
AR012032A1 (es) 2000-09-27
KR100561326B1 (ko) 2006-03-16
NO993876D0 (no) 1999-08-11
CN1246864A (zh) 2000-03-08
AU725274B2 (en) 2000-10-12
AU6260898A (en) 1998-09-08
BR9807349A (pt) 2000-04-25
PL187357B1 (pl) 2004-06-30
CN1326865C (zh) 2007-07-18
ZA98986B (en) 1998-08-05
HUP0001330A2 (hu) 2000-08-28
CZ294481B6 (cs) 2005-01-12
EP0966477B1 (en) 2003-10-15
WO1998035976A1 (en) 1998-08-20
DE69818977T2 (de) 2004-08-12
PT966477E (pt) 2004-03-31
BG103673A (en) 2000-02-29
CA2279932C (en) 2008-04-22
CZ270499A3 (cs) 1999-11-17
BG64099B1 (bg) 2003-12-31
CA2279932A1 (en) 1998-08-20
NZ336482A (en) 2001-02-23
HUP0001330A3 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
NO993876L (no) 3'-N-oksid, 3'-N-dimetylamin, 9-oksim erytromycin A derivater
ES2188896T3 (es) Derivados de 3'-dimetilamina, 9-eteroxima eritromicina a, protegida en 2'.
US6096714A (en) Erythromycin derivatives, method for preparing same, and use thereof as drugs
MX9703548A (es) Proceso para purificar y aislar 2'-desoxi-2',2'-difluoronucleosidos.
HU193886B (en) Process for preparing epimer azahomoerythromycin a derivatives
TR199901578T2 (xx) Klaritromisin form 0 kristali
EP0394496A4 (en) Glycoside derivatives, polymers containing glycoside derivatives, process for their preparation, and use of said polymers
US4526889A (en) Epimeric azahomoerythromycin A derivative, intermediates and method of use
CA2246909A1 (en) Method for chemical synthesis of oligonucleotides
IE821260L (en) Anthracycline derivatives
HUP0004085A2 (hu) A 9a-azaleidek csoportjához tartozó, új 3,6-hemiketálszármazékok
PL348607A1 (en) Novel intermediates, process for preparing macrolide antibiotic agent therefrom
GEP20032899B (en) 5-O-Deosaminyl 6-O-Methyl Erythronolide A Derivatives and Method for Their Preparation
Barron et al. An equimolar mixture of quercetin 3-sulphate and patuletin 3-sulphate from Flaveria chloraefolia
EP0124216A1 (en) C-20- and C-23-modified macrolide derivatives
EP1122252A4 (en) CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM
HK27689A (en) Sialic acid derivatives and process for the preparation thereof
MY133397A (en) Novel crystalline forms of a macrolide antibiotic
AU7304394A (en) TTTr as protective group in nucleotide synthesis
BG106123A (en) Diphosphate salt of a 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin derivative and its pharmaceutical composition
EP1328535A1 (en) Macrolides
CA2108817A1 (en) Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation
JPS55151598A (en) Erythromycin a derivative and its preparation
AU3067900A (en) Novel derivatives from the class of oleandomycin
US4661588A (en) 23-O-substituted carbamoyl-23-demycinosyldesmycosin

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application